Blue Peel Consent Form Template: Screening & Protocol Guide

Key Takeaways

The Blue Peel uses trichloroacetic acid (TCA) to deeply exfoliate and resurface skin, making it the most intensive Obagi offering for treating hyperpigmentation, fine lines, and acne scarring.

Clinicians must screen for contraindications including pregnancy, active infections, isotretinoin use within the past 6 months, and Fitzpatrick skin types IV-VI at higher risk of post-inflammatory hyperpigmentation.

Informed consent documentation covering risks, recovery expectations, and patient acknowledgment is non-negotiable. Regulatory bodies (CQC, GDPR) require written evidence of patient understanding.

Pabau’s digital consent forms, aftercare messaging, and treatment record templates eliminate paper-based workflows, improve compliance tracking, and centralize treatment history for audit readiness.

The blue peel is one of the most requested treatments in aesthetic practices today, and one of the most misunderstood. It is an advanced TCA chemical peel that demands careful screening, detailed informed consent, and a strict aftercare protocol, since one overlooked contraindication can turn a routine resurfacing session into a liability claim.

Here is how to screen candidates safely, run the protocol with confidence, and document every step.

What is the blue peel, and how does it work?

The blue peel is a professional-strength chemical peel developed by Obagi Medical, using trichloroacetic acid (TCA) as its active exfoliant.

The original formulation includes a blue pigment that slows TCA penetration, letting practitioners apply the solution methodically and control the depth of exfoliation. The blue dye washes away during neutralization, giving the treatment its name and its clinical safety advantage.

TCA is a non-selective exfoliant. It denatures skin proteins, triggers a controlled inflammatory response, and stimulates collagen remodeling.

Unlike gentler alpha-hydroxy acids (AHAs) used in superficial peels, TCA penetrates the dermis, making the blue peel a medium-to-deep procedure. This depth delivers dramatic results for sun damage, age spots, and acne scars, but it requires careful candidate selection, written consent, and realistic downtime communication.

Obagi also offers Blue Peel Radiance, a newer salicylic acid variant positioned as a gentler entry point into blue peel treatments. Understanding the difference between the two formulations is essential for practice scheduling and patient counseling.

Blue peel vs Blue Peel Radiance: Which one fits your patient?

Choosing between the original blue peel (TCA) and its successor (Radiance) depends on patient skin type, concern severity, and downtime tolerance.

Here is the clinical distinction:

The trade-off is clear. Blue peel (TCA) delivers superior results but requires real patient buy-in on recovery time, while Radiance offers a quicker turnaround but demands more frequent treatments for similar improvement.

Skin type often drives the decision. Darker skin (Fitzpatrick IV-VI) typically starts with Radiance to minimize post-inflammatory hyperpigmentation (PIH), while lighter skin tolerates the deeper action of the original blue peel.

Who is a good candidate for the blue peel?

• Ideal candidates: Adults aged 25 to 65 with sun-damaged or Fitzpatrick I-III skin, seeking treatment for hyperpigmentation, fine lines, acne scarring, or overall skin texture improvement. Patients must commit to 5 to 10 days of downtime and strict aftercare compliance.
• Contraindications (absolute): Pregnancy or breastfeeding, active infections (herpes simplex, bacterial), open wounds, isotretinoin (Accutane) use within the past 6 months, current hydroquinone or tretinoin therapy without a 4-week washout, a history of keloid formation, or immunosuppression.
• Relative contraindications (exercise caution; may require medical director approval): Darker Fitzpatrick skin types (IV-VI) at elevated PIH risk, a history of melasma, active acne, recent laser or microdermabrasion, or unrealistic outcome expectations. These patients may be better served by Blue Peel Radiance or an alternative treatment.

Pre-treatment preparation checklist

Successful blue peel outcomes depend on a meticulous pre-treatment protocol. Skin must be primed, medications paused, and realistic expectations set. Use digital consent forms to send this checklist 1 to 2 weeks ahead, and track completion through your practice portal.

1. Discontinue all active treatments – Stop tretinoin, retinol, hydroquinone, vitamin C serums, and exfoliating acids 4 weeks prior. These thin the stratum corneum and increase irritation risk.
2. Avoid sun exposure – Maintain strict SPF 50 sunscreen daily. Tanned or sun-exposed skin has unpredictable peel depth and higher PIH risk.
3. Review medications with medical director – Aspirin, NSAIDs, and blood thinners increase bleeding and bruising risk; antihistamines may be needed.
4. Confirm contraindication absence – Screen verbally and in writing for pregnancy, active infections, isotretinoin, and immunosuppression.
5. Arrange aftercare support – Patients should plan for 5 to 10 days off work and social commitments; identify a caregiver if severe downtime is expected.
6. Obtain written informed consent – Cover the procedure description, expected outcome, risks (infection, scarring, PIH, prolonged erythema), and acknowledgment of downtime.

Document all pre-treatment steps in a treatment record template linked to the patient’s file. This creates a clear audit trail if complications arise.

What happens during a blue peel treatment

The blue peel procedure typically takes 15 to 30 minutes. Here is the step-by-step sequence that practitioners and support staff should follow precisely:

1. Cleanse the face thoroughly – Remove makeup, sunscreen, and oils with a gentle facial cleanser and pat dry. Ensure skin is completely dry before peel application.
2. Apply protective barriers – Petroleum jelly or barrier cream around the eyes, lips, and nostrils to prevent irritant contact.
3. Apply TCA solution methodically – Using a brush or cotton applicator, apply the blue peel in thin, even strokes across the face or targeted area. The blue color shows coverage. Stop once even blue coverage is achieved.
4. Monitor for frosting – A white “frost” (denatured protein layer) forms within 2 to 5 minutes. This indicates adequate penetration. Darker skin may show less visible frosting, so rely on experience and practitioner judgment.
5. Neutralize the peel – Apply a neutralizing solution (typically sodium bicarbonate or a water rinse, per product instructions) thoroughly. The blue dye washes away. Make sure neutralization is complete to stop the acid reaction.
6. Apply soothing treatment – Pat the skin dry gently, then apply a hydrating serum or prescribed aftercare balm. Avoid occlusive creams immediately post-peel.
7. Provide aftercare instructions verbally and in writing – Hand the patient a printed aftercare sheet, then send aftercare instructions by email or patient portal.

Document the treatment in the patient’s clinical record. Note the solution concentration, application time, frosting achieved, any complications, and aftercare recommendations. Practice management software like Pabau can capture that dictation in real time through Pabau Scribe, its AI scribe, so notes stay accurate without adding to your post-treatment admin.

Blue peel aftercare instructions for patients

Aftercare determines whether a patient heals beautifully or develops complications. Provide written instructions before they leave, then reinforce them by automated SMS or email within 2 hours of treatment.

• Days 1-3 (Immediate healing phase): Avoid water and makeup; cleanse gently with cool distilled water only. Apply prescribed aftercare balm 4 to 6 times daily. Sleep with the head elevated on 2 to 3 pillows. Avoid hot showers, exercise, saunas, and alcohol.
• Days 4-7 (Active peeling): Use a gentle facial cleanser (no scrubbing) twice daily. Moisturize heavily with fragrance-free products. Continue SPF 50+ sunscreen even indoors. Do NOT pick or pull peeling skin. Let it shed naturally.
• Days 8-14 (Skin renewal): Peeling typically subsides; introduce a gentle hydrating serum. Begin light sun protection; sunscreen is non-negotiable. Avoid chemical exfoliants, retinoids, and vitamin C until skin fully normalizes (typically 2 weeks post-peel).
• Weeks 3-4 and beyond: Erythema (redness) may persist 2 to 4 weeks. Resume normal skincare gradually. Do NOT resume tretinoin or active treatments until medical director approval (typically 4 weeks minimum).

Red flags requiring immediate contact: signs of infection (pus, warmth, fever), persistent blistering beyond day 3, or an allergic reaction (severe swelling, hives). Link aftercare documentation in the patient record for quick reference.

Recovery timeline and downtime expectations

Patients often underestimate recovery. Set expectations clearly in your consent process to prevent dissatisfaction and negative reviews.

• Days 0-2: Significant erythema (redness), mild swelling. Skin feels tight and warm. Visible frosting may be present.
• Days 3-5: Active peeling begins; skin flakes and sheds. Appearance is notably compromised, so patients should avoid public-facing activities.
• Days 6-10: Peeling intensity decreases; new skin underneath is pink and fragile.
• Week 2-3: Most visible peeling has resolved; residual erythema softens. Patients can return to light activities and makeup use.
• Week 4+: Erythema may persist but is increasingly subtle. Full skin maturation and final results emerge over 4 to 8 weeks as collagen remodels.

The original blue peel (TCA) has a longer downtime than Radiance. Make sure patients understand they are committing to about 1 to 1.5 weeks of visible recovery. Document the downtime discussion in compliance records to demonstrate informed consent.

Blue peel consent form: what to include

A legally sound consent form is your practice’s first line of defense. It must cover the procedure description, expected results, material risks, and patient acknowledgment, without overwhelming or frightening the patient.

This is also where practice setup guides often fall short. Regulatory bodies (CQC in the UK, state medical boards in the US) expect detailed written evidence of informed consent, and dermatology EMR software that stores the signed form alongside the clinical record makes that evidence easy to produce.

Essential sections your blue peel consent form must include:

• Procedure description: A clear, non-technical explanation of what a TCA chemical peel is and how it works (exfoliation, collagen stimulation, expected depth).
• Expected benefits: A realistic list (reduction in sun damage, fine lines, and hyperpigmentation) without guarantees of permanent or complete resolution.
• Contraindications: Use tiered disclosure. List absolute contraindications (pregnancy, active infection) separately from relative contraindications (darker skin types, melasma history) the patient is being screened for.
• Material risks: Infection, scarring, post-inflammatory hyperpigmentation, prolonged erythema, adverse reaction to chemicals, and rare but serious complications (ectropion if applied too close to the eyes).
• Downtime and activity restrictions: A specific timeline (5-10 days visible peeling, 2-4 weeks residual redness) and which activities are restricted (sun exposure, exercise, makeup, exfoliants).
• Aftercare requirements: Non-negotiable steps (sunscreen, moisturizer, no active treatments for 4 weeks) and the consequences of non-compliance (worse outcomes, increased complications).
• Alternative treatments: Briefly mention alternatives, such as a dermaplaning consult, laser resurfacing, or microneedling, so the patient confirms the blue peel is their informed choice.
• Patient signature and date: Accompanied by a witness signature (often the practice staff member discussing consent) and the practitioner’s signature and credentials (medical director or provider administering).

Use Pabau’s digital consent form builder to create a template that patients sign electronically before arrival. The system timestamps signatures and automatically files them in the patient record, satisfying GDPR and CQC audit requirements without manual paperwork.

How Pabau helps practices manage blue peel treatments

Managing blue peel workflows, from consent to aftercare to compliance tracking, historically meant juggling paper forms, email reminders, and spreadsheets.

Pabau centralizes the entire blue peel journey. Digital consent forms go out before the appointment, automated aftercare messaging fires at treatment completion, treatment notes stay structured in the clinical record, and compliance documentation stays ready for audit.

Practices like Skin With Bea Esthetics now send consent forms before appointments instead of during them, and Pabau customers save an average of 10 hours a week on admin, according to Pabau’s 2025 Customer Impact Report.

The system’s pre-appointment screening forms can be customized to flag blue peel contraindications. Your staff knows before the patient walks in whether isotretinoin use or a darker skin type calls for special precautions. Post-treatment, automated SMS sends aftercare instructions with practice contact details, cutting down follow-up calls and improving patient adherence to the recovery protocol. If your practice also bills insurance for medically necessary treatments, such as actinic keratosis alongside cosmetic resurfacing, keep a CMS-1500 form on hand for that portion of care.

Simplify blue peel consent and aftercare with Pabau

Pabau's digital consent forms, automated aftercare messaging, and structured treatment notes take the admin out of every blue peel appointment, so your team can focus on patient care.

Book a demo

Conclusion

The blue peel remains one of the most dramatic and effective tools in aesthetic medicine, but only for practices that run pre-treatment screening, informed consent, and aftercare with precision. Use the downloadable consent form and the checklists above to standardize your protocol, reduce liability risk, and deliver consistent, safe outcomes your patients trust.

If your practice also offers dermal fillers, a separate dermal filler consent form keeps that workflow just as tight. For the blue peel itself, book a demo to see how digital consent, automated aftercare, and centralized treatment records simplify delivery at scale.

Continue your research

Need a gentler alternative on the menu? The green peel template gives you a consent and protocol framework for a lighter peel option.

Screening a new blue peel candidate? A skin analysis form helps you document baseline skin type and concerns before you commit to a protocol.

Running peels beyond the blue peel line? A general chemical peel consent form covers the broader TCA and AHA peel menu.

Need a structured first visit? An aesthetic consultation template captures goals and history before you recommend a peel.

Patients asking about gentler resurfacing? Dermabrasion aftercare instructions cover a comparable recovery process.

Frequently asked questions